0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma

Clinical trial NCT00729807 · TERMINATED

Trial details

NCT number: NCT00729807
Sponsor: University of Maryland, Baltimore
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2008-07-01
Primary completion: 2012-08-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.